bsm-52220R-Cy5 [Conjugated Primary Antibody]
PPAR gamma Recombinant Antibody, Cy5 Conjugated
www.biossusa.com
support@biossusa.com
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: PPAR gamma

Clonality: Recombinant

Isotype: IgG

Entrez Gene: 5468

Swiss Prot: P37231

Source: Recombinant human PPAR gamma protein, around 100-200aa.

Purification: Purified by Protein A.

Storage Buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Background:

The PPAR gamma antibody mainly is exist in the white fat organization, the fat for the PPAR gamma is born, blood sugar stability, the disease respond, the artery gruel kind hardens to rise the important function with the tumor occurrence of etc. all, but concerning the PPAR gamma to bone of function is a new research heat to order in recent years.A PPAR of many researches report gamma was go together with the body is after activate can the function promote many capable cells divided to increase to living but repress the ossification cell to divide to cause the bone measure the decrease or bone softs toward the fat cell in the marrow, the PPAR gamma promotes the ability and bones that the fat cell divide metabolize closely related, the performance is increasing along with the growth marrow fat content of the age, the ossification cell metabolism the outcome reduce, the different construction PPAR gamma 2 have the important function.

Conjugation: Cy5

Excitation/ Emission: 625,650nm/670nm

Size: 100µL

Concentration: Lot dependent

Applications: WB(1:500-2000)
IF(1:200-1000)

Cross Reactive Species: Human
Rat

Predicted Cross Reactive Species: Mouse

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Fadian Ding. et al. Adropin attenuates pancreatitis?associated lung injury through PPAR phosphorylation?related macrophage polarization. INT J MOL MED. 2023 Oct;52(4):1-1Read more>>
VALIDATION IMAGES